Compare Binh Dinh Pharmaceutical & Medical Equipment JSC with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
VND 4,724,463 Million (Small Cap)
17.00
NA
3.17%
-0.25
16.75%
2.72
Revenue and Profits:
Net Sales:
448,087 Million
(Quarterly Results - Mar 2026)
Net Profit:
80,298 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.6%
0%
-4.6%
6 Months
1.97%
0%
1.97%
1 Year
-0.77%
0%
-0.77%
2 Years
-1.33%
0%
-1.33%
3 Years
12.36%
0%
12.36%
4 Years
-12.94%
0%
-12.94%
5 Years
12.85%
0%
12.85%
Binh Dinh Pharmaceutical & Medical Equipment JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.99%
EBIT Growth (5y)
13.37%
EBIT to Interest (avg)
70.23
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
1.03
Tax Ratio
15.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.57%
ROE (avg)
17.11%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.94
EV to EBIT
14.19
EV to EBITDA
12.27
EV to Capital Employed
3.59
EV to Sales
2.47
PEG Ratio
3.76
Dividend Yield
2.97%
ROCE (Latest)
25.32%
ROE (Latest)
16.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
448,086.90
509,951.70
-12.13%
Operating Profit (PBDIT) excl Other Income
91,395.80
71,108.10
28.53%
Interest
840.20
1,002.00
-16.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
80,297.80
59,493.10
34.97%
Operating Profit Margin (Excl OI)
182.30%
114.60%
6.77%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -12.13% vs 15.98% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 34.97% vs -0.69% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,865,379.60
1,727,548.40
7.98%
Operating Profit (PBDIT) excl Other Income
377,297.20
353,704.60
6.67%
Interest
3,846.60
4,058.10
-5.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
251,022.30
236,656.50
6.07%
Operating Profit Margin (Excl OI)
174.90%
176.90%
-0.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 7.98% vs 4.59% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 6.07% vs 2.28% in Dec 2024
About Binh Dinh Pharmaceutical & Medical Equipment JSC 
Binh Dinh Pharmaceutical & Medical Equipment JSC
Pharmaceuticals & Biotechnology
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
Company Coordinates 
Company Details
498 Nguyen Thai Hoc, Phuong Quang Trung , QUI NHON None : None
Registrar Details






